Patent Yard Sign in
Expired Canadian patentCanada

Process for preparing sertraline intermediates

CA 1285574 C · Owner: Pfizer Inc. · Inventors: Quallich, George Joseph; Williams, Michael Trevelyan

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A novel three-step process for preparing 4-(3,4dichlorophenyl)-4-phenylbutanoic acid is disclosed which involves (1) reducing 4-(3,4-dichlorophenyl)- 4-ketobutanoic acid to 4-(3,4-dichlorophenyl)-4hydroxybutanoic acid; (2) then converting the intermediate hydroxy acid formed in the first step to 5-(3,4-dichlorophenyl)-dihydro-2(3H)-furanone and (3), thereafter reacting the resulting gamma-butyrolactone compound with benzene in a Friedel-Crafts type reaction to form the desired final product. The latter compound is known to be useful as an intermediate leading to 4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone and ultimately, to …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted July 2, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended July 2, 2008.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 9, 1988
GrantedJuly 2, 1991
Term endedJuly 2, 2008
Patent numberCA 1285574 C
Classification (IPC)C07C49/69 +2 more

Timeline

Timeline From CIPO dates

1989199119931995199719992001200320052007Application filedJune 9, 1988Patent grantedJuly 2, 1991Term endedJuly 2, 2008

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.